Minaris And Bluebird Bio Enter Manufacturing Pact | Contract Pharma
National Resilience to buy bluebird bio's Durham facility for $110M - Triangle Business Journal
bluebird bio opens manufacturing facility in Durham, looks to add 20 workers in '19 | WRAL TechWire
bluebird bio Stock: Beaten Down Biotech With Long-Term Potential (NASDAQ:BLUE) | Seeking Alpha
Hitachi Chemical Advanced Therapeutics Solutions, apceth Biopharma GmbH and bluebird bio to collaborate on strategic clinical and commercial manufacturing - Express Pharma
Bluebird buys manufacturing site to produce viral vector as it advances gene therapies | Fierce Pharma
apceth Biopharma joins Lonza as bluebird bio cell therapy contractor
Bluebird Bio and Resilience Announce Strategic Alliance | citybiz
Bluebird Bio Has Serious Cash Flow Concerns; Inability To Strike Reimbursement Deals In Europe Partly To Blame
SEC Filing - bluebird bio, Inc.
Bluebird Bio and Resilience Announce Strategic Alliance to Develop Next Generation Cell Therapies | Business Wire
Bluebird bio opens lentiviral vector manufacturing facility
Bluebird Bio and Resilience Announce Strategic Alliance to Develop Next Generation Cell Therapies | Business Wire
blue-ex991_6.htm
Bluebird Bio: On The Cusp Of A Gene Therapy Revolution
Drug Discovery News on Twitter: "bluebird bio opens its 1st wholly-owned manufacturing facility in #Durham, NC, spending >$80M 125K sq-ft facility will produce lentiviral vectors for company's #GeneTherapy & #CellTherapy efforts https://t.co/9MAi4hWqYp #
Apceth bullish on manufacturing deal with bluebird bio
Bluebird opens manufacturing facility as it moves gene therapies forward | Fierce Pharma
Bluebird bio to Sell Durham Plant in Strategic Alliance with Biomanufacturer | North Carolina Biotechnology Center
Bluebird Bio (BLUE) FDA Panel Ruling on Gene Therapy Drug May Help Stock - Bloomberg
bluebird bio plans 'new nest' around hybrid work model
CDMO Apceth Biopharma Inks Manufacturing Agreement With Bluebird Bio - Pharmaceutical Processing World
Inside bluebird bio's decision to open biotech manufacturing facility in Durham | WRAL TechWire
Bluebird Bio (BLUE) FDA Panel Ruling on Gene Therapy Drug May Help Stock - Bloomberg
Bluebird's Latest Gene Therapy Stumble Will Help Vertex Close The Gap :: Scrip
blue-ex991_25.htm
Thomas Leitch - Vice President, Manufacturing - bluebird bio | LinkedIn
MilliporeSigma Signs Commercial Supply Agreement with bluebird bio for Viral Vector Manufacturing
